At a Glance
| Dextroamphetamine | 2-FMA | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (insufflated) | 7.5–12 mg | 15–30 mg |
| Total Duration | 1.1–2.3 hrs | 1.5–4 hrs |
| Routes | insufflatedoral | insufflated |
Dextroamphetamine, a Stimulants, and 2-FMA, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 16 documented effects in common, with 4 effects unique to Dextroamphetamine and 35 unique to 2-FMA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Dextroamphetamine | 2-FMA | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (insufflated) | 7.5–12 mg | 15–30 mg |
| Total Duration | 1.1–2.3 hrs | 1.5–4 hrs |
| Routes | insufflatedoral | insufflated |
| Effects | 20 documented | 51 documented |
| Level | Dextroamphetamine | 2-FMA |
|---|---|---|
| Threshold | 3 mg | 5 mg |
| Light | 3–7.5 mg | 5–15 mg |
| Common | 7.5–12 mg | 15–30 mg |
| Strong | 12–21.5 mg | 30–50 mg |
| Heavy | 21.5 mg | 50 mg |
| Level | Dextroamphetamine | 2-FMA |
|---|---|---|
| Threshold | 3.75 mg | 5 mg |
| Light | 3.75–10 mg | 5–15 mg |
| Common | 10–16 mg | 15–30 mg |
| Strong | 16–30 mg | 30–50 mg |
| Heavy | 30 mg | 50 mg |
Dextroamphetamine
2-FMA
Dextroamphetamine
No direct interaction data available between these substances. This does not mean the combination is safe.
2-FMA